| Year |
Citation |
Score |
| 2024 |
Mistry AM, Saver J, Mack W, Kamel H, Elm J, Beall J. Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades. Stroke. PMID 38235584 DOI: 10.1161/STROKEAHA.123.044790 |
0.351 |
|
| 2023 |
Mistry AM, Saver J, Mack W, Kamel H, Elm J, Beall J. Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades. Medrxiv : the Preprint Server For Health Sciences. PMID 37873354 DOI: 10.1101/2023.09.28.23296257 |
0.335 |
|
| 2023 |
Chamberlain JM, Kapur J, Silbergleit RS, Elm JJ, Rosenthal ES, Bleck TP, Shinnar S, Zetabchi S, Evans SR. Desirability of Outcome Ranking for Status Epilepticus (DOOR STEP): A Benefit-Risk Approach to Design and Analyses of Clinical SE Trials. Neurology. PMID 37580166 DOI: 10.1212/WNL.0000000000207684 |
0.314 |
|
| 2023 |
Zhao W, Yeatts SD, Broderick JP, Selim MH, Adeoye OM, Durkalski-Mauldin VL, Meinzer CN, Martin RH, Dillon CR, Cassarly CN, Pauls KH, Elm JJ. Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. Stroke. PMID 37078281 DOI: 10.1161/STROKEAHA.122.040743 |
0.35 |
|
| 2022 |
Broderick JP, Aziz YN, Adeoye OM, Grotta JC, Naidech AM, Barreto AD, Derdeyn CP, Sucharew HJ, Elm JJ, Khatri P. Recruitment in Acute Stroke Trials: Challenges and Potential Solutions. Stroke. PMID 36533521 DOI: 10.1161/STROKEAHA.122.040071 |
0.358 |
|
| 2021 |
de Havenon A, Sheth KN, Madsen TE, Johnston KC, Turan TN, Toyoda K, Elm JJ, Wardlaw JM, Johnston SC, Williams OA, Shoamanesh A, Lansberg MG. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. Stroke. STROKEAHA121035002. PMID 34517768 DOI: 10.1161/STROKEAHA.121.035002 |
0.38 |
|
| 2021 |
Naidech A, Grotta JC, Elm J, Janis S, Dowlatshahi D, Toyoda K, Steiner T, Mayer SA, Khanolkar P, Denlinger J, Audebert HJ, Molina C, Khatri P, Sprigg N, Vagal A, et al. EXPRESS: Recombinant Factor VIIa for Hemorrhagic Stroke Treatment at Earliest Possible Time (FASTEST): Protocol for a Phase III, Double-Blind, Randomized, Placebo-Controlled Trial. International Journal of Stroke : Official Journal of the International Stroke Society. 17474930211042700. PMID 34427473 DOI: 10.1177/17474930211042700 |
0.307 |
|
| 2020 |
Meschia JF, Walton RL, Farrugia LP, Ross OA, Elm JJ, Farrant M, Meurer WJ, Lindblad AS, Barsan W, Ching M, Gentile N, Ross M, Nahab F, Easton JD, Kim AS, et al. Efficacy of Clopidogrel for Prevention of Stroke Based on Allele Status in the POINT Trial. Stroke. 51: 2058-2065. PMID 32568642 DOI: 10.1161/Strokeaha.119.028713 |
0.426 |
|
| 2020 |
Keator LM, Basilakos A, Rorden C, Elm J, Bonilha L, Fridriksson J. Clinical Implementation of Transcranial Direct Current Stimulation in Aphasia: A Survey of Speech-Language Pathologists. American Journal of Speech-Language Pathology. 1-13. PMID 32437243 DOI: 10.1044/2020_Ajslp-19-00037 |
0.326 |
|
| 2020 |
Sathe AG, Elm JJ, Cloyd JC, Chamberlain JM, Silbergleit R, Kapur J, Cock HR, Fountain NB, Shinnar S, Lowenstein DH, Conwit RA, Bleck TP, Coles LD. The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus. Epilepsia. PMID 32420641 DOI: 10.1111/Epi.16534 |
0.314 |
|
| 2020 |
Cucchiara B, Elm J, Easton JD, Coutts SB, Willey JZ, Biros MH, Ross MA, Johnston SC. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial. Stroke. 51: 792-799. PMID 32078486 DOI: 10.1161/Strokeaha.119.027465 |
0.397 |
|
| 2019 |
Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, Shinnar S, Conwit R, Meinzer C, Cock H, Fountain N, Connor JT, Silbergleit R. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. The New England Journal of Medicine. 381: 2103-2113. PMID 31774955 DOI: 10.1056/Nejmoa1905795 |
0.333 |
|
| 2019 |
Cock HR, Coles LD, Elm J, Silbergleit R, Chamberlain JM, Cloyd JC, Fountain N, Shinnar S, Lowenstein D, Conwit R, Bleck TP, Kapur J. Lessons from the Established Status Epilepticus Treatment Trial. Epilepsy & Behavior : E&B. 106296. PMID 31653603 DOI: 10.1016/J.Yebeh.2019.04.049 |
0.385 |
|
| 2019 |
Park Y, Fullerton HJ, Elm JJ. A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial. Contemporary Clinical Trials. 105852. PMID 31614215 DOI: 10.1016/J.Cct.2019.105852 |
0.447 |
|
| 2019 |
Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Martí-Fàbregas J, Bernstein RA, et al. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Jama Network Open. 2: e1910769. PMID 31490536 DOI: 10.1001/jamanetworkopen.2019.10769 |
0.595 |
|
| 2019 |
Pan Y, Elm JJ, Li H, Easton JD, Wang Y, Farrant M, Meng X, Kim AS, Zhao X, Meurer WJ, Liu L, Dietrich D, Wang Y, Johnston SC. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. Jama Neurology. PMID 31424481 DOI: 10.1001/Jamaneurol.2019.2531 |
0.396 |
|
| 2019 |
Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, Cucchiara BL, Kleindorfer DO, Lutsep HL, Pearson C, Sethi P, et al. Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial. Circulation. PMID 31238700 DOI: 10.1161/Circulationaha.119.040713 |
0.614 |
|
| 2019 |
Sathe AG, Tillman H, Coles LD, Elm JJ, Silbergleit R, Chamberlain J, Kapur J, Cock HR, Fountain NB, Shinnar S, Lowenstein DH, Conwit RA, Bleck TP, Cloyd JC. Underdosing of Benzodiazepines in Patients with Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. PMID 31161706 DOI: 10.1111/Acem.13811 |
0.308 |
|
| 2019 |
Tillman H, Johnston SC, Farrant M, Barsan W, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Easton JD. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. Jama Neurology. PMID 31034032 DOI: 10.1001/Jamaneurol.2019.0932 |
0.612 |
|
| 2019 |
Wilmskoetter J, Bonilha L, Martin-Harris B, Elm JJ, Horn J, Bonilha HS. Factors Influencing Oral Intake Improvement and Feeding Tube Dependency in Patients with Poststroke Dysphagia. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 30962081 DOI: 10.1016/J.Jstrokecerebrovasdis.2019.03.031 |
0.301 |
|
| 2019 |
Wilmskoetter J, Bonilha L, Martin-Harris B, Elm JJ, Horn J, Bonilha HS. Mapping acute lesion locations to physiological swallow impairments after stroke. Neuroimage. Clinical. 22: 101685. PMID 30711683 DOI: 10.1016/J.Nicl.2019.101685 |
0.326 |
|
| 2018 |
Cohen S, Waks Z, Elm JJ, Gordon MF, Grachev ID, Navon-Perry L, Fine S, Grossman I, Papapetropoulos S, Savola JM. Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington disease. Bmc Medical Informatics and Decision Making. 18: 138. PMID 30572891 DOI: 10.1186/S12911-018-0714-7 |
0.408 |
|
| 2018 |
Kimberly WT, Bevers MB, von Kummer R, Demchuk AM, Romero JM, Elm JJ, Hinson HE, Molyneaux BJ, Simard JM, Sheth KN. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. PMID 30446594 DOI: 10.1212/Wnl.0000000000006618 |
0.409 |
|
| 2018 |
Murphy MP, Kuramatsu JB, Leasure A, Falcone GJ, Kamel H, Sansing LH, Kourkoulis C, Schwab K, Elm JJ, Gurol ME, Tran H, Greenberg SM, Viswanathan A, Anderson CD, Schwab S, et al. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage. Stroke. 49: 2652-2658. PMID 30355194 DOI: 10.1161/Strokeaha.118.021799 |
0.379 |
|
| 2018 |
Fridriksson J, Basilakos A, Stark BC, Rorden C, Elm J, Gottfried M, George MS, Sen S, Bonilha L. Transcranial direct current stimulation to treat aphasia: Longitudinal analysis of a randomized controlled trial. Brain Stimulation. PMID 30318184 DOI: 10.1016/J.Brs.2018.09.016 |
0.338 |
|
| 2018 |
Fridriksson J, Elm J, Stark BC, Basilakos A, Rorden C, Sen S, George MS, Gottfried M, Bonilha L. BDNF genotype and tDCS interaction in aphasia treatment. Brain Stimulation. PMID 30150003 DOI: 10.1016/J.Brs.2018.08.009 |
0.342 |
|
| 2018 |
Fridriksson J, Rorden C, Elm J, Sen S, George MS, Bonilha L. Transcranial Direct Current Stimulation vs Sham Stimulation to Treat Aphasia After Stroke: A Randomized Clinical Trial. Jama Neurology. PMID 30128538 DOI: 10.1001/Jamaneurol.2018.2287 |
0.341 |
|
| 2018 |
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. The New England Journal of Medicine. PMID 29766750 DOI: 10.1056/Nejmoa1800410 |
0.605 |
|
| 2018 |
Wilmskoetter J, Martin-Harris B, Pearson WG, Bonilha L, Elm JJ, Horn J, Bonilha HS. Differences in swallow physiology in patients with left and right hemispheric strokes. Physiology & Behavior. PMID 29758228 DOI: 10.1016/J.Physbeh.2018.05.010 |
0.306 |
|
| 2017 |
Hinson VK, Delambo A, Elm J, Turner T. A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease. Movement Disorders Clinical Practice. 4: 416-423. PMID 30363371 DOI: 10.1002/Mdc3.12455 |
0.355 |
|
| 2017 |
Biffi A, Kuramatsu JB, Leasure A, Kamel H, Kourkoulis C, Schwab K, Ayres AM, Elm J, Gurol ME, Greenberg SM, Viswanathan A, Anderson CD, Schwab S, Rosand J, Testai FD, et al. Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage. Annals of Neurology. PMID 29028130 DOI: 10.1002/Ana.25079 |
0.302 |
|
| 2017 |
Broderick JP, Adeoye O, Elm J. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials Stroke. 48: 2007-2012. PMID 28626052 DOI: 10.1161/Strokeaha.117.017866 |
0.423 |
|
| 2017 |
Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, et al. Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377: 137-143. PMID 28477684 DOI: 10.1016/J.Jns.2017.04.011 |
0.313 |
|
| 2016 |
Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, et al. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. Journal of Parkinson's Disease. PMID 27911341 DOI: 10.3233/Jpd-160965 |
0.353 |
|
| 2016 |
Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine CW, Schneider JS. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism & Related Disorders. PMID 27743701 DOI: 10.1016/J.Parkreldis.2016.10.005 |
0.355 |
|
| 2016 |
Augustine EF, Dorsey ER, Hauser RA, Elm JJ, Tilley BC, Kieburtz KK. Communicating with participants during the conduct of multi-center clinical trials. Clinical Trials (London, England). PMID 27573636 DOI: 10.1177/1740774516665596 |
0.358 |
|
| 2016 |
Sheth KN, Elm JJ, Molyneaux BJ, Hinson H, Beslow LA, Sze GK, Ostwaldt AC, Del Zoppo GJ, Simard JM, Jacobson S, Kimberly WT. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet. Neurology. PMID 27567243 DOI: 10.1016/S1474-4422(16)30196-X |
0.397 |
|
| 2016 |
Turner TH, Renfroe JB, Elm J, Duppstadt-Delambo A, Hinson VK. Robustness of Reliable Change Indices to Variability in Parkinson's Disease with Mild Cognitive Impairment. Applied Neuropsychology. Adult. 1-4. PMID 27144494 DOI: 10.1080/23279095.2016.1160907 |
0.333 |
|
| 2016 |
Weintraub D, Hauser RA, Elm JJ, Pagan F, Davis MD, Choudhry A. Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27030249 DOI: 10.1002/Mds.26617 |
0.335 |
|
| 2016 |
Sheth KN, Simard JM, Elm J, Kronenberg G, Kunte H, Kimberly WT. Human Data Supporting Glyburide in Ischemic Stroke. Acta Neurochirurgica. Supplement. 121: 13-8. PMID 26463916 DOI: 10.1007/978-3-319-18497-5_3 |
0.389 |
|
| 2015 |
Revuelta GJ, Embry A, Elm JJ, Gregory C, Delambo A, Kautz S, Hinson VK. Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait. Translational Neurodegeneration. 4: 24. PMID 26693006 DOI: 10.1186/S40035-015-0047-8 |
0.331 |
|
| 2015 |
Bega D, Kim S, Zhang Y, Elm J, Schneider J, Hauser R, Fraser A, Simuni T. Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort. Journal of Parkinson's Disease. PMID 26639661 DOI: 10.3233/Jpd-150668 |
0.329 |
|
| 2015 |
Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B. Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects. Journal of Parkinson's Disease. PMID 26444095 DOI: 10.3233/Jpd-150666 |
0.318 |
|
| 2015 |
Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocritical Care. PMID 26268138 DOI: 10.1007/S12028-015-0189-7 |
0.402 |
|
| 2015 |
Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O. Sex Differences in Clinical Features of Early, Treated Parkinson's Disease. Plos One. 10: e0133002. PMID 26171861 DOI: 10.1371/Journal.Pone.0133002 |
0.373 |
|
| 2015 |
Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, Nogueira RG, Elm JJ, Graves T, Berry S, Lees KR, Barreto AD, Saver JL. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale. Stroke; a Journal of Cerebral Circulation. 46: 2238-43. PMID 26138130 DOI: 10.1161/Strokeaha.114.008547 |
0.401 |
|
| 2015 |
Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/Jama.2015.120 |
0.451 |
|
| 2015 |
Creanor S, Vickery J, Eyre V, Zajicek J, Ball S, Elm J, Carroll C. Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease Trials. 16: 236. DOI: 10.1186/1745-6215-16-S2-P236 |
0.459 |
|
| 2014 |
Elm JJ, Palesch Y, Easton JD, Lindblad A, Barsan W, Silbergleit R, Conwit R, Dillon C, Farrant M, Battenhouse H, Perlmutter A, Johnston SC. Screen failure data in clinical trials: Are screening logs worth it? Clinical Trials (London, England). 11: 467-472. PMID 24925082 DOI: 10.1177/1740774514538706 |
0.587 |
|
| 2014 |
Sheth KN, Kimberly WT, Elm JJ, Kent TA, Yoo AJ, Thomalla G, Campbell B, Donnan GA, Davis SM, Albers GW, Jacobson S, del Zoppo G, Simard JM, Stern BJ, Mandava P. Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocritical Care. 21: 43-51. PMID 24671831 DOI: 10.1007/S12028-014-9970-2 |
0.361 |
|
| 2014 |
Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K. Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial Movement Disorders. 29: 263-265. PMID 24323565 DOI: 10.1002/Mds.25734 |
0.374 |
|
| 2014 |
Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, Thomalla G, Campbell B, Donnan GA, Davis SM, Albers GW, Jacobson S, Simard JM, Stern BJ. Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke; a Journal of Cerebral Circulation. 45: 281-3. PMID 24193798 DOI: 10.1161/Strokeaha.113.003352 |
0.401 |
|
| 2014 |
Kimberly WT, Battey TW, Pham L, Wu O, Yoo AJ, Furie KL, Singhal AB, Elm JJ, Stern BJ, Sheth KN. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocritical Care. 20: 193-201. PMID 24072459 DOI: 10.1007/S12028-013-9917-Z |
0.345 |
|
| 2013 |
Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J. The established status epilepticus trial 2013. Epilepsia. 54: 89-92. PMID 24001084 DOI: 10.1111/Epi.12288 |
0.417 |
|
| 2013 |
Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. International Journal of Stroke : Official Journal of the International Stroke Society. 8: 479-83. PMID 23879752 DOI: 10.1111/Ijs.12129 |
0.609 |
|
| 2013 |
Connor JT, Elm JJ, Broglio KR. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. Journal of Clinical Epidemiology. 66: S130-7. PMID 23849147 DOI: 10.1016/J.Jclinepi.2013.02.015 |
0.391 |
|
| 2013 |
Yoo AJ, Sheth KN, Kimberly WT, Chaudhry ZA, Elm JJ, Jacobson S, Davis SM, Donnan GA, Albers GW, Stern BJ, González RG. Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: 742-9. PMID 22325573 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.01.002 |
0.326 |
|
| 2012 |
Luo S, Lawson AB, He B, Elm JJ, Tilley BC. Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial. Statistical Methods in Medical Research. PMID 23242384 DOI: 10.1177/0962280212469358 |
0.409 |
|
| 2012 |
Elm JJ. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1513-21. PMID 23079770 DOI: 10.1002/Mds.25175 |
0.455 |
|
| 2012 |
Elm JJ, Palesch YY, Koch GG, Hinson V, Ravina B, Zhao W. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. Journal of Biopharmaceutical Statistics. 22: 758-72. PMID 22651113 DOI: 10.1080/10543406.2010.528103 |
0.576 |
|
| 2012 |
Tilley BC, Mainous AG, Elm JJ, Pickelsimer E, Soderstrom LH, Ford ME, Diaz VA, Siminoff LA, Burau K, Smith DW. A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy. Clinical Trials (London, England). 9: 188-97. PMID 22496398 DOI: 10.1177/1740774512436881 |
0.438 |
|
| 2012 |
Meurer WJ, Lewis RJ, Tagle D, Fetters MD, Legocki L, Berry S, Connor J, Durkalski V, Elm J, Zhao W, Frederiksen S, Silbergleit R, Palesch Y, Berry DA, Barsan WG. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Annals of Emergency Medicine. 60: 451-7. PMID 22424650 DOI: 10.1016/J.Annemergmed.2012.01.020 |
0.695 |
|
| 2012 |
Sheth K, Yoo A, Gonzalez R, Kimberly W, Chaudhry Z, Elm J, Jacobson S, Davis S, Donnan G, Albers G, Stern B. Hemisphere Volume Is Associated with Neurological Deterioration and Outcome after Malignant Infarction (P07.034) Neurology. 78: P07.034-P07.034. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.034 |
0.353 |
|
| 2012 |
Tanner C, Kieburtz K, Galpern W, Delong M, Dickson D, Elm J, Faroud T, Kamp C, Lang A, Marder K, Marek K, Pfeiffer R, Ross G, Siderowf A, Weintraub D. 1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT Parkinsonism & Related Disorders. 18: S10-S11. DOI: 10.1016/S1353-8020(11)70117-1 |
0.374 |
|
| 2010 |
Schneider JS, Elm JJ, Parashos SA, Ravina BM, Galpern WR. Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Parkinsonism & Related Disorders. 16: 507-12. PMID 20598621 DOI: 10.1016/J.Parkreldis.2010.06.001 |
0.317 |
|
| 2009 |
Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1732-9. PMID 19514076 DOI: 10.1002/Mds.22645 |
0.625 |
|
| 2007 |
Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease Neurology. 69: 342-347. PMID 17581943 DOI: 10.1212/01.Wnl.0000268695.63392.10 |
0.317 |
|
| 2007 |
Elm JJ, Kamp C, Tilley BC, Guimaraes P, Fraser D, Deppen P, Brocht A, Weaver C, Bennett S. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 822-7. PMID 17357141 DOI: 10.1002/Mds.21409 |
0.368 |
|
| 2006 |
Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 66: 628-33. PMID 16534099 DOI: 10.1212/01.Wnl.0000201251.33253.Fb |
0.605 |
|
| 2005 |
Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials (London, England). 2: 509-18. PMID 16422311 DOI: 10.1191/1740774505Cn125Oa |
0.598 |
|
| 2005 |
Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology. 57: 197-203. PMID 15668964 DOI: 10.1002/Ana.20361 |
0.587 |
|
| 2004 |
Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Elm JJ, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurorx. 1: 506-514. DOI: 10.1602/Neurorx.1.4.506 |
0.497 |
|
| 2004 |
Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Elm JJ, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurotherapeutics. 1: 506-514. DOI: 10.1007/BF03206636 |
0.45 |
|
| Show low-probability matches. |